Literature DB >> 730071

Measurement of fasting and postprandial plasma VIP in man.

S J Mitchell, S R Bloom.   

Abstract

A specific radioimmunoassay has been developed capable of detecting 1.5 pmol VIP/l plasma with 95% confidence. The antisera employed reacted most avidly with whole VIP, partly with C terminal, but not with N terminal fragments. In 110 healthy fasting volunteers plasma VIP concentrations were estimated to lie between 0.5 and 21 pmol/l (median 1.7). No significant change was seen after ingestion of a standard test meal.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 730071      PMCID： PMC1412230          DOI： 10.1136/gut.19.11.1043

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


  14 in total

1.  Elevated plasma and tissue levels of vasoactive intestinal polypeptide in the watery-diarrhea syndrome due to pancreatic, bronchogenic and other tumors.

Authors:  S I Said; G R Faloona
Journal:  N Engl J Med       Date:  1975-07-24       Impact factor: 91.245

2.  Current problems in the measurement of gastrin release. A reproducible measure of physiological gastrin release.

Authors:  R C Russel; S R Bloom; L P Fielding; M G Bryant
Journal:  Postgrad Med J       Date:  1976-10       Impact factor: 2.401

3.  Vasoactive intestinal peptide stimulation of adenylate cyclase and active electrolyte secretion in intestinal mucosa.

Authors:  C J Schwartz; D V Kimberg; H E Sheerin; M Field; S I Said
Journal:  J Clin Invest       Date:  1974-09       Impact factor: 14.808

4.  Vasoactive intestinal peptide and watery-diarrhoea syndrome.

Authors:  S R Bloom; J M Polak; A G Pearse
Journal:  Lancet       Date:  1973-07-07       Impact factor: 79.321

5.  Hyperglycemic and glycogenolytic effects of vasoactive intestinal polypeptide.

Authors:  C Kerins; S I Said
Journal:  Proc Soc Exp Biol Med       Date:  1973-03

6.  Isolation from porcine-intestinal wall of a vasoactive octacosapeptide related to secretin and to glucagon.

Authors:  S I Said; V Mutt
Journal:  Eur J Biochem       Date:  1972-07-13

7.  Polypeptide with broad biological activity: isolation from small intestine.

Authors:  S I Said; V Mutt
Journal:  Science       Date:  1970-09-18       Impact factor: 47.728

8.  Possible dual role for vasoactive intestinal peptide as gastrointestinal hormone and neurotransmitter substance.

Authors:  M G Bryant; M M Polak; I Modlin; S R Bloom; R H Albuquerque; A G Pearse
Journal:  Lancet       Date:  1976-05-08       Impact factor: 79.321

9.  Glucagon levels in normal and diabetic subjects: use of a specific immunoabsorbent for glucagon radioimmunoassay.

Authors:  F P Alford; S R Bloodm; J D Nabarro
Journal:  Diabetologia       Date:  1977-01       Impact factor: 10.122

10.  Proceedings: The distribution of vasoactive intestinal peptide (VIP) in the primate gastrointestinal tract and characterization of VIP from human tumours.

Authors:  S R Bloom; M G Bryant
Journal:  Gut       Date:  1973-10       Impact factor: 23.059
View more
  56 in total

1.  Gut regulatory peptides and intestinal permeability in acute infantile gastroenteritis.

Authors:  G R Lawson; R Nelson; M F Laker; M A Ghatei; S R Bloom; A Aynsley-Green
Journal:  Arch Dis Child       Date:  1992-03       Impact factor: 3.791

2.  Colonic responses to enteral tube feeding.

Authors:  T E Bowling; D B Silk
Journal:  Gut       Date:  1998-02       Impact factor: 23.059

3.  Regulatory peptides in the respiratory tract of Macaca fascicularis.

Authors:  M A Ghatei; D R Springall; I M Richards; J A Oostveen; R L Griffin; A Cadieux; J M Polak; S R Bloom
Journal:  Thorax       Date:  1987-06       Impact factor: 9.139

4.  Failure to detect plasma neuropeptide release during trigeminal thermocoagulation.

Authors:  H Schon; D T Thomas; D A Jewkes; M A Ghatei; P K Mulderry; S R Bloom
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-05       Impact factor: 10.154

5.  Somatostatin, gastrointestinal peptides, and the carcinoid syndrome.

Authors:  R G Long; J R Peters; S R Bloom; M R Brown; W Vale; J E Rivier; D G Grahame-Smith
Journal:  Gut       Date:  1981-07       Impact factor: 23.059

6.  Intractable diarrhoea in a patient with vasoactive intestinal peptide-secreting neuroblastoma. Attempted control by somatostatin.

Authors:  K Tiedemann; J Pritchard; R Long; S R Bloom
Journal:  Eur J Pediatr       Date:  1981-10       Impact factor: 3.183

7.  Elevated levels of vasoactive intestinal peptide in the eye and urinary bladder of diabetic and prediabetic Chinese hamsters.

Authors:  A R Diani; T Peterson; G A Sawada; B M Wyse; M C Blanks; G C Gerritsen; G Terenghi; I M Varndell; J M Polak; M A Blank
Journal:  Diabetologia       Date:  1985-05       Impact factor: 10.122

8.  Effect of infused vasoactive intestinal peptide on airway function in normal subjects.

Authors:  J B Palmer; F M Cuss; J B Warren; M Blank; S R Bloom; P J Barnes
Journal:  Thorax       Date:  1986-09       Impact factor: 9.139

9.  Vasoactive intestinal peptide (VIP).

Authors:  M G Bryant
Journal:  J Clin Pathol Suppl (Assoc Clin Pathol)       Date:  1978

10.  Effects of vasoactive intestinal peptide and pancreatic polypeptide in rabbit intestine.

Authors:  M Camilleri; B T Cooper; T E Adrian; S R Bloom; V S Chadwick
Journal:  Gut       Date:  1981-01       Impact factor: 23.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.